Medical News

RSS

Opinions: Counterfeit medicines; oral rehydration therapy in Bangladesh; increasing access to safe drinking water; attracting R&D for health issues in Latin America

"The Obama administration and Congress should continue efforts to strengthen the safety of America's drug supply and, simultaneously, coordinate a global response to the problem of counterfeit drugs," Thomas Kubic, president & CEO of the Pharmaceutical Security Institute and a former deputy assistant director at the FBI, writes in a post on The Hill's "Congress Blog," where he describes the health risks associated with such drugs.

23 Mar 2011

Cellerant commences CLT-008 Phase I/II trial in patients with leukemia

Cellerant Therapeutics Inc., a biotechnology company developing novel hematopoietic stem cell-based cellular and antibody therapies for blood disorders and cancer, announced the initiation of a Phase I/II clinical trial of CLT-008 in patients receiving intensive post-remission chemotherapy for high-risk leukemia or myelodysplasia.

23 Mar 2011

High-fiber diets during early adult years may reduce lifetime risk of cardiovascular disease

A new study from Northwestern Medicine shows a high-fiber diet could be a critical heart-healthy lifestyle change young and middle-aged adults can make.

23 Mar 2011

WMU receives $100 million cash gift for new medical school

A $100 million cash gift, the largest ever made to a Michigan college or university, will be used to give birth to a private medical school at a public institution--Western Michigan University.

23 Mar 2011

PRWP receives two new patents for Galectin-targeting compounds in the U.S., Australia

Pro-Pharmaceuticals, Inc., the leading developer of therapeutics that target Galectin receptors to treat cancer and fibrosis, today announced that the Company has been granted two new patents, "Co-administration of a Polysaccharide with a Chemotherapeutic Agent for the Treatment of Cancer" in Australia and "Selectively Depolymerized Galactomannan Polysaccharide" in the United States.

23 Mar 2011

SGEN, Abbott enter collaboration agreement for ADC products

Seattle Genetics, Inc.today announced that it has entered into a collaboration agreement with Abbott under which Abbott will pay an upfront fee of $8 million for rights to utilize Seattle Genetics' antibody-drug conjugate technology with antibodies to a single oncology target.

23 Mar 2011

Children have a hard time spotting biased information or exaggerated claims

A UT Dallas researcher is examining how children evaluate information to solve problems and learn how to think critically, with the aim of combating misleading advertising aimed at young people.

23 Mar 2011

WSJ: U.S. Disability Fund may run out of cash

The SSDI is set to soon become the first big federal benefit program to run out of cash — and one of the main reasons is U.S. states and territories have a large say in who qualifies for the federally funded program.

23 Mar 2011

POZEN files motion for Treximet patent litigation against Par

POZEN Inc., a pharmaceutical company committed to transforming medicines that transform lives, today announced that it has filed a motion for a preliminary injunction seeking to prevent Par Pharmaceuticals, Inc. from launching a generic version of Treximet.

23 Mar 2011

Genetic errors in women linked to increased risk of preeclampsia

Scientists have identified genetic errors in women with autoimmune diseases that increase the risk of preeclampsia, a potentially life-threatening condition that occurs in 10 percent of all pregnancies.

23 Mar 2011

Strong 'innate immunity' effective in chikungunya patients

Chikungunya is transmitted by mosquitoes of the genus Aedes. The disease is spreading in the world and periodically sparks new outbreaks. Africa, Asia, the Indian Ocean and even Southern Europe are now affected.

23 Mar 2011

Organochloride pesticide exposure can alter semen quality in young people

Two in 10 young people in South East Spain have poor sperm density, which involves requiring more time to accomplish fertilization. The most common means of exposure to pesticides is food and other household products.

23 Mar 2011

UDL enters license agreement with Humeca for burn, wound care products

Mylan Inc. today announced that its subsidiary UDL Laboratories, part of the Mylan Institutional business, has entered a license agreement with Humeca, a leading plastic surgery and burn treatment products company, for the exclusive U.S. distribution rights of Humeca products.

23 Mar 2011

NeoTract initiates patient enrollment for UroLift System trial to treat prostrate cancer

NeoTract, Inc. a medical device company focused on developing urology devices, today announced that the first U.S. patients have been enrolled in a multinational trial of its UroLift® System at Western Urological Clinic in Salt Lake City, Utah.

23 Mar 2011

Roundup: HHS Secretary's ability to waive Medicaid requirements; Kansas seeks more funding for disability programs

U.S. Health and Human Services Secretary Kathleen Sebelius has broad legal authority to waive Medicaid maintenance-of-effort requirements, according to a memo from the Congressional Research Service to the U.S. Senate Finance Committee.

23 Mar 2011

CABC offers first-ever PEM-guided accessory for breast biopsy

The Center for Advanced Breast Care is the first comprehensive breast center in the Chicago area to add Positron Emission Mammography-guided biopsy capability to its already extensive breast cancer care services.

23 Mar 2011

Enrollment complete in Aradigm's inhaled ciprofloxacin Phase 2b study in non-cystic fibrosis bronchiectasis

Aradigm Corporation announced the last patient was enrolled in a Phase 2b study designed to evaluate the Company's inhaled liposomal ciprofloxacin (CFI, ARD-3100) in patients with non-cystic fibrosis bronchiectasis (BE), a severe progressive respiratory disease for which there is currently no approved treatment in the U.S.

23 Mar 2011

New Deloitte report: Consumers spend $363 billion on health care

As health care reform marks its one-year anniversary, a new Deloitte report reveals that consumers are spending $363 billion, or 14.7 percent more, on health care than traditionally reported in official government accounts.

23 Mar 2011

Astellas announces positive results from mirabegron phase III trials against OAB

Astellas Pharma Inc. today announced the results of two pivotal phase III clinical trials for mirabegron, the first of a new class of compounds under development for the treatment of overactive bladder, show mirabegron significantly improves key OAB symptoms - urinary incontinence and frequency of micturition.

23 Mar 2011

AstraZeneca, Senectus sign deal to identify compounds that trigger cancer cell ageing

Senectus Therapeutics has signed a deal to screen a selection of AstraZeneca's chemical compound library to identify those which trigger a key element of cancer cell ageing - called senescence.

23 Mar 2011

Medical News

Opinions: Counterfeit medicines; oral rehydration therapy in Bangladesh; increasing access to safe drinking water; attracting R&D for health issues in Latin America

Cellerant commences CLT-008 Phase I/II trial in patients with leukemia

High-fiber diets during early adult years may reduce lifetime risk of cardiovascular disease

WMU receives $100 million cash gift for new medical school

PRWP receives two new patents for Galectin-targeting compounds in the U.S., Australia

SGEN, Abbott enter collaboration agreement for ADC products

Children have a hard time spotting biased information or exaggerated claims

WSJ: U.S. Disability Fund may run out of cash

POZEN files motion for Treximet patent litigation against Par

Genetic errors in women linked to increased risk of preeclampsia

Strong 'innate immunity' effective in chikungunya patients

Organochloride pesticide exposure can alter semen quality in young people

UDL enters license agreement with Humeca for burn, wound care products

NeoTract initiates patient enrollment for UroLift System trial to treat prostrate cancer

Roundup: HHS Secretary's ability to waive Medicaid requirements; Kansas seeks more funding for disability programs

CABC offers first-ever PEM-guided accessory for breast biopsy

Enrollment complete in Aradigm's inhaled ciprofloxacin Phase 2b study in non-cystic fibrosis bronchiectasis

New Deloitte report: Consumers spend $363 billion on health care

Astellas announces positive results from mirabegron phase III trials against OAB

AstraZeneca, Senectus sign deal to identify compounds that trigger cancer cell ageing

Advancing brain microphysiological systems (bMPS)

PhD researcher at LifeArc

Unveiling Hidden Potential: Organoids for Disease Modeling in Neuroscience Research

Latest News